Quantcast
Last updated on April 16, 2014 at 5:14 EDT

Latest Sexual dysfunction Stories

2012-03-22 02:24:50

GREENWOOD VILLAGE, Colo. and GOIANIA, GOIAS, Brazil, March 22, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), and FBM Industria Farmaceutica Ltda ("FBMFarma"), a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma...

2012-03-15 07:00:00

Erectile dysfunction is a common problem for men who have diabetes, and Advanced Male Medical Center, offering treatments in the San Francisco area for erectile dysfunction and premature ejaculation, features solutions for patients to get their sex life back. San Francisco, CA (PRWEB) March 15, 2012 San Francisco male impotence specialist, Advanced Male Medical Center, specializing in removing the difficulties that keep men from having a sex life, understands that diabetics often experience...

2012-03-08 06:30:00

CRANBURY, N.J., March 8, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced it has completed enrollment in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for treatment of female sexual dysfunction (FSD). Over 400 premenopausal women, diagnosed with female sexual arousal disorder, hypoactive sexual desire disorder or both, have been enrolled in the study. Patients, who will undergo 16 weeks of treatment, will be randomized to one...

2012-03-08 04:00:00

JERSEY CITY, N.J., March 8, 2012 /PRNewswire/ -- S1 Pharmaceuticals, Inc., a developer of therapeutics for disorders of women's sexual health, announced today an executive management addition and Scientific Advisory Board appointment to strengthen and expand the Company's leadership, as follows: Robert E. Pyke, MD, PhD, a member of the S1 Advisory Board of Directors since October 2011 was appointed as the Company's Chief Medical Officer. Molly A. Katz, MD was appointed as a member of the...

March Is Endometriosis Awareness Month
2012-03-01 09:40:06

Leading organization celebrates 15th annual recognition effort honoring women and girls with painful condition The Endometriosis Research Center (ERC) is pleased to once again honor those with endometriosis through the organization´s 15th annual “Awareness Month” recognition.  Often stigmatized as merely “killer cramps,” endometriosis is a poorly-understood disease characterized by pelvic pain, painful menstruation, infertility and pregnancy loss, pain...

2012-02-21 04:00:00

JERSEY CITY, N.J., Feb. 21, 2012 /PRNewswire/ -- S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug Administration for Phase I-b clinical studies of SIP-104 (Lorexys). Lorexys is the Company's lead drug candidate for the treatment of Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Dysfunction (FSD). Lorexys' clinical development plan is based on pharmacokinetic and safety data...

2012-02-13 07:30:00

FORT LAUDERDALE, Fla., Feb. 13, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals (soon to be changed from Hybrid Fuels, Inc., Pink Sheets: HRID) announced today that the Company is working on a formulation of an all-natural product to help the millions of females suffering with female sexual dysfunction (FSD). Approximately 43% of American women experience sexual dysfunction. Unfortunately, pharmaceutical treatments are limited; no drugs have yet been approved for the condition in the...

2012-02-10 09:00:00

More men suffer from premature ejaculation (PE) than any other sexual dysfunction, twice that of the more recognized erectile dysfunction. But there have been no safe and effective treatments for PE until now with the introduction of Promescent, an FDA approved, over-the-counter medication. Promescent is already being hailed as the only go-to treatment by medical experts and thought leaders worldwide. Newport Beach, California (PRWEB) February 10, 2012 Premature Ejaculation (PE) affects...

2012-02-09 16:00:00

GREENWOOD VILLAGE, Colo., Feb. 9, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced financial results for the year ended December 31, 2011, and offered a summary of the milestones during 2011. Financial Results Total revenues recognized for the year ended December 31, 2011, were $18,750, reflecting the amortized portion...

2012-01-23 10:38:57

(Ivanhoe Newswire) — If you have stable cardiovascular disease, it is more than likely that you can safely engage in sexual activity. "Sexual activity is a major quality of life issue for men and women with cardiovascular disease and their partners. Unfortunately, discussions about sexual activity rarely take place in the clinical context," quoted Glenn N. Levine, M.D., professor of medicine at Baylor College of Medicine in Houston, Texas was quoted as saying. According to the...